REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Recent Decisions > 2015 >

Decisions 3rd March 2015

New Drug Requests



Lidocaine 5% topical Patch (Versatis®) (TLS Red)

  • Approved in the management of pain secondary to isolated rib fractures. 

Methoxsalen (Uvadex®) (TLS Red)

  • Approved for use in the Bristol Apheresis unit.


More information required

Infliximab Biosimilars (Inflectra® and Remsima®)

  • Approved for inclusion onto the formulary.

Aclidinium bromide and Formoterol fumarate (Duaklir Genuair®)

  • Await SMC advice.  


Shared Care Protocols/TLS Change in Status

Naltrexone (Opiates/alcohol)

  • More work required to make them more concise.

Lanthanum SCP

  • Updated SCP agreed. 

Sevelamer (Renagel®) SCP

  • Updated SCP agreed.



Other inclusions agreed to the formulary:

Ajmaline (TLS Red)

  • Approved for inclusion onto the formulary for use in the diagnostic tests for Brugada syndrome. Previosuly approved through UHB MAG.

Meningitis B vaccine (TLS Blue)

  • Approved for inclusion onto the formulary as the Department of Health recommend the vaccine for those without a functioning spleen.